#49 - Michael Demurjian, Founder & CEO at Aspargo Laboratories
Update: 2025-05-27
Description
Join us on the latest episode! Our Guest: Michael Demurjian, Founder & CEO at Aspargo Laboratories.
What you'll get out of this episode:
- Aspargo tackles inefficiencies in pill-based drug delivery through innovative oral suspensions.
- The company’s patented technology improves absorption via buccal and GI routes.
- First commercial product, HisQ (oral spray sildenafil), delivers rapid ED treatment in just 10 minutes—even on a full stomach.
- Future products include sprays for weight loss and hair loss, launching via a telehealth platform.
- Upcoming smart dispenser connects with physicians and caregivers for enhanced adherence and monitoring.
To Learn More About Our Guest And Their Company:
Guest LinkedIn https://www.linkedin.com/in/michael-demurjian-02868113/
Company LinkedIn https://www.linkedin.com/company/aspargo-laboratories-inc/
Website https://aspargolabs.com/
Our sponsor for this episode are:
Sage Growth Partners https://sage-growth.com/
BioBreakthroughs is part of the Slice of Healthcare podcast network:
LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
